Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,200 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase II trial of concurrent chemoradiotherapy with S-1 plus cisplatin in patients with unresectable locally advanced squamous cell carcinoma of the head and neck: Japan Clinical Oncology Group Study (JCOG0706).
Nakamura K, Tahara M, Kiyota N, Hayashi R, Akimoto T, Fukuda H, Fujii M, Boku N. Nakamura K, et al. Among authors: akimoto t. Jpn J Clin Oncol. 2009 Jul;39(7):460-3. doi: 10.1093/jjco/hyp040. Epub 2009 May 8. Jpn J Clin Oncol. 2009. PMID: 19429640 Clinical Trial.
Brachytherapy for penile cancer using silicon mold.
Akimoto T, Mitsuhashi N, Takahashi I, Yonome I, Takahashi M, Hayakawa K, Niibe H. Akimoto T, et al. Oncology. 1997 Jan-Feb;54(1):23-7. doi: 10.1159/000227656. Oncology. 1997. PMID: 8978588
[Radiation therapy for head and neck cancer].
Mitsuhashi N, Akimoto T, Hayakawa K, Muramatsu H, Niibe H. Mitsuhashi N, et al. Among authors: akimoto t. Nihon Igaku Hoshasen Gakkai Zasshi. 2001 Jan;61(1):10-6. Nihon Igaku Hoshasen Gakkai Zasshi. 2001. PMID: 11218740 Review. Japanese.
Salvage external beam radiotherapy for local recurrence without systemic progression or prostate specific antigen recurrence of prostate cancer after initial hormonal therapy: is it possible to identify patients likely to have good treatment outcomes?
Kurokawa K, Ito K, Suzuki K, Ono Y, Yamamoto T, Akimoto T, Yamanaka H. Kurokawa K, et al. Among authors: akimoto t. Jpn J Clin Oncol. 2002 Nov;32(11):466-71. doi: 10.1093/jjco/hyf096. Jpn J Clin Oncol. 2002. PMID: 12499419
1,200 results